Skip to main content

Table 2 Univariate and multivariate cox regression analysis for overall survival in patients with ESCC

From: Impact of type 2 diabetes mellitus on short-term and long-term outcomes of patients with esophageal squamous cell cancer undergoing resection: a propensity score analysis

Characteristic

Univariate analysis

Multivariate analysis

HR

95% CI

P value

HR

95% CI

P value

Age (years)

 ≤ 45 vs. 46–59 vs. ≥ 60

1.002

0.990–1.015

0.720

Sex

 Female vs. male

0.769

0.607–0.975

0.030

0.865

0.680–1.101

0.239

Smoking status

 Yes vs. no

1.176

0.944–1.465

0.149

Drinking status

 Yes vs. no

1.195

0.922–1.548

0.178

Weight loss rate

 0 vs. > 0% to ≤ 5.0% vs. > 5.0% to ≤ 10.0% vs. > 10.0%

1.168

1.047–1.302

0.005

1.118

1.000–1.251

0.060

BMI (kg/m2)

 < 18.5 vs. ≥ 18.5 to < 25.0 vs. ≥ 25.0

0.970

0.779–1.207

0.784

Tumor location

 Upper vs. middle vs. lower

0.932

0.767–1.134

0.483

Tumor grade

 G1 vs. G2 vs. G3

1.489

1.271–1.745

< 0.001

1.373

1.164–1.621

< 0.001

pT category

 T1 vs. T2 vs. T3 vs. T4

1.642

1.308–2.062

< 0.001

1.257

0.982–1.611

0.070

pN category

 N0 vs. N1 vs. N2 vs. N3

1.820

1.594–2.079

< 0.001

1.474

1.181–1.839

0.001

pTNM stage

 Stage I vs. stage II vs. stage III

2.270

1.832–2.813

< 0.001

1.237

0.872–1.754

0.233

Complications

 None vs. anastomotic leakage vs. pneumonia vs. others

1.118

0.961–1.299

0.148

T2DM

 With T2DM vs. without T2DM

0.896

0.719–1.116

0.326

  1. ESCC esophageal squamous cell carcinoma, BMI body mass index, T2DM type 2 diabetes mellitus, pT pathological tumor, pN pathological node, pTNM stage pathological tumor/node/metastasis, HR hazard ratio, 95% CI 95% confidence interval, no comparison